Davis Investment Partners’s Novartis NVS Stock Holding History

Davis Investment Partners’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$887K	Hold	5,658	–	–	0.27%	62
2026 Q1	$864K	Buy	+5,658	New	+$867K	0.31%	58

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Davis Investment Partners's NVS Position: Q2 2026 in Review

Davis Investment Partners held its Novartis (NVS) position steady in Q2 2026 at 5,658 shares worth $887K. The position accounts for 0.27% of the portfolio, ranked #62.

Davis Investment Partners first reported a position in NVS in Q1 2026 and has held it in 2 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Davis Investment Partners held 5,658 shares of Novartis worth $887K as of Q2 2026.
Davis Investment Partners left its Novartis share count unchanged in Q2 2026.
Novartis made up 0.27% of Davis Investment Partners's portfolio in Q2 2026, its #62 holding.
Davis Investment Partners first reported a position in Novartis in Q1 2026 and has held it in 2 quarters since.
1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Davis Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.